Skip to main content
. 2019 Jul 8;39(7):BSR20180551. doi: 10.1042/BSR20180551

Figure 6. MiR-197-3p inhibitor reversed the promoting effects of LIFR-AS1 knockdown on breast cancer cells.

Figure 6

(A) Cell proliferation was determined by CCK8 assays after transfection with miR-197 mimics or miR-197 inhibitor. (B) Cell invasion was detected via Transwell invasion assays after transfection with miR-197 mimics or miR-197 inhibitor. (C) MDA-MB-415 cell proliferation was examined by CCK8 assays after co-transfection of miR-197-3p inhibitor and siLIFR-AS1. (D) Clonogenic ability of MDA-MB-415 cells were determined by colony formation assays after co-transfection of miR-197-3p inhibitor and siLIFR-AS1. (E) MDA-MB-415 cell migration was examined by wound healing assays after co-transfection of miR-197-3p inhibitor and siLIFR-AS. (F) MDA-MB-415 cell invasion was determined by transwell invasion assays after co-transfection of miR-197-3p inhibitor and siLIFR-AS1. (G) Sufu protein expression in MDA-MB-415 cells was detected by Western blot analysis after co-transfection of miR-197-3p inhibitor and siLIFR-AS1. **P<0.01, ***P<0.001.